Dr. Jorge J. Nieva, MD Associate Professor of Clinical Medicine University of Southern California discusses a study conducted by Memorial Sloan Cancer Center in where the objectives were Validate the CCP gene signature (CCP score) and a Prognostic Score that identify stage I non-small cell lung cancer patients with a higher risk of cancer-related death after surgical resection
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content